Arca Biopharma | ABIO - Operating Profit

Arca Biopharma reported $-5680000 in Operating Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Operating Profit Change
Amgen AMGN:US USD 2.23B 508M
Biogen BIIB:US USD 699.9M 615.2M
Brainstorm Cell Therapeutics BCLI:US USD -6841000 750K
Bristol Myers Squibb BMY:US USD 1.94B 528M
Capricor Therapeutics CAPR:US USD -8066000 1.59M
Cytokinetics CYTK:US USD -127030000 3.66M
Cytrx CYTR:US USD -1294610 7.73M
Daiichi Sankyo 4568:JP JPY 31.55B 29.65B
Gilead Sciences GILD:US USD 2.27B 570M
GlaxoSmithKline GSK:LN GBP 1.87B 677M
Laboratory Of America LH:US USD 90.7M 378.7M
Myriad Genetics MYGN:US USD -52200000 7.2M
Otsuka Holdings 4578:JP JPY 35.48B 12.23B
Pfizer PFE:US USD 5.17B 4.24B
United Therapeutics UTHR:US USD 175.6M 138.7M